Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125920799> ?p ?o ?g. }
- W2125920799 endingPage "1629" @default.
- W2125920799 startingPage "1600" @default.
- W2125920799 abstract "Fragment-based lead generation (FBLG) has recently emerged as an alternative to traditional high throughput screening (HTS) to identify initial chemistry starting points for drug discovery programs. In comparison to HTS screening libraries, the screening sets for FBLG tend to contain orders of magnitude fewer compounds, and the compounds themselves are less structurally complex and have lower molecular weight. This report summarises the advent of FBLG within the industry and then describes the FBLG experience at AstraZeneca. We discuss (1) optimising the design of screening libraries, (2) hit detection methodologies, (3) evaluation of hit quality and use of ligand efficiency calculations, and (4) approaches to evolve fragment-based, low complexity hits towards drug-like leads. Furthermore, we exemplify our use of FBLG with case studies in the following drug discovery areas: antibacterial enzyme targets, GPCRs (melanocortin 4 receptor modulators), prostaglandin D2 synthase inhibitors, phosphatase inhibitors (protein tyrosine phosphotase 1B), and protease inhibitors (b-secretase)." @default.
- W2125920799 created "2016-06-24" @default.
- W2125920799 creator A5000800114 @default.
- W2125920799 creator A5003421505 @default.
- W2125920799 creator A5005482561 @default.
- W2125920799 creator A5007726602 @default.
- W2125920799 creator A5010916394 @default.
- W2125920799 creator A5020130403 @default.
- W2125920799 creator A5047608401 @default.
- W2125920799 creator A5052458915 @default.
- W2125920799 creator A5053834801 @default.
- W2125920799 creator A5059014687 @default.
- W2125920799 creator A5072100659 @default.
- W2125920799 creator A5078872253 @default.
- W2125920799 creator A5088068003 @default.
- W2125920799 creator A5090436170 @default.
- W2125920799 date "2007-08-01" @default.
- W2125920799 modified "2023-10-17" @default.
- W2125920799 title "An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes" @default.
- W2125920799 cites W1209134892 @default.
- W2125920799 cites W1502177285 @default.
- W2125920799 cites W1509196567 @default.
- W2125920799 cites W1522908541 @default.
- W2125920799 cites W1602507232 @default.
- W2125920799 cites W1604884792 @default.
- W2125920799 cites W1680932833 @default.
- W2125920799 cites W1854324009 @default.
- W2125920799 cites W1969314179 @default.
- W2125920799 cites W1971553338 @default.
- W2125920799 cites W1972091733 @default.
- W2125920799 cites W1979555076 @default.
- W2125920799 cites W1979598348 @default.
- W2125920799 cites W1983592663 @default.
- W2125920799 cites W1984596640 @default.
- W2125920799 cites W1986240377 @default.
- W2125920799 cites W1988564488 @default.
- W2125920799 cites W1989003785 @default.
- W2125920799 cites W1989605329 @default.
- W2125920799 cites W1996100382 @default.
- W2125920799 cites W1996259120 @default.
- W2125920799 cites W1999711931 @default.
- W2125920799 cites W2000960726 @default.
- W2125920799 cites W2001870435 @default.
- W2125920799 cites W2002092012 @default.
- W2125920799 cites W2005208748 @default.
- W2125920799 cites W2006641674 @default.
- W2125920799 cites W2007272508 @default.
- W2125920799 cites W2008312146 @default.
- W2125920799 cites W2008525757 @default.
- W2125920799 cites W2011391967 @default.
- W2125920799 cites W2014989916 @default.
- W2125920799 cites W2016584130 @default.
- W2125920799 cites W2016627771 @default.
- W2125920799 cites W2019414596 @default.
- W2125920799 cites W2024278225 @default.
- W2125920799 cites W2024438870 @default.
- W2125920799 cites W2026177652 @default.
- W2125920799 cites W2029739433 @default.
- W2125920799 cites W2029834129 @default.
- W2125920799 cites W2031609935 @default.
- W2125920799 cites W2032353075 @default.
- W2125920799 cites W2032447576 @default.
- W2125920799 cites W2035979361 @default.
- W2125920799 cites W2039244194 @default.
- W2125920799 cites W2039609369 @default.
- W2125920799 cites W2040830259 @default.
- W2125920799 cites W2042338355 @default.
- W2125920799 cites W2043360059 @default.
- W2125920799 cites W2043468131 @default.
- W2125920799 cites W2046052555 @default.
- W2125920799 cites W2046940215 @default.
- W2125920799 cites W2047186114 @default.
- W2125920799 cites W2047710091 @default.
- W2125920799 cites W2047756206 @default.
- W2125920799 cites W2048522660 @default.
- W2125920799 cites W2048966170 @default.
- W2125920799 cites W2050535564 @default.
- W2125920799 cites W2051710717 @default.
- W2125920799 cites W2059518315 @default.
- W2125920799 cites W2059998193 @default.
- W2125920799 cites W2060880753 @default.
- W2125920799 cites W2061151008 @default.
- W2125920799 cites W2065389660 @default.
- W2125920799 cites W2066668212 @default.
- W2125920799 cites W2068261875 @default.
- W2125920799 cites W2069667670 @default.
- W2125920799 cites W2077481897 @default.
- W2125920799 cites W2082047157 @default.
- W2125920799 cites W2085419794 @default.
- W2125920799 cites W2089802355 @default.
- W2125920799 cites W2090020204 @default.
- W2125920799 cites W2091864876 @default.
- W2125920799 cites W2092565093 @default.
- W2125920799 cites W2096410114 @default.
- W2125920799 cites W2098933757 @default.
- W2125920799 cites W2114068014 @default.
- W2125920799 cites W2117135374 @default.
- W2125920799 cites W2117643210 @default.